In this study, we show evidence of LAIR1 as one receptor for PTIC through an in vitro analysis of THP-1 cells polarized to M1 and in circulating Mos of symptomatic COVID-19 outpatients on treatment with an intramuscular administration of PTIC. Here, LAIR1 is linked to COVID-19.